| Display title | Chemistry:PipISB |
| Default sort key | PipISB |
| Page length (in bytes) | 2,941 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 38085 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image | Error creating thumbnail: Unable to save thumbnail to destination |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>ScienceGen |
| Date of page creation | 23:09, 5 February 2024 |
| Latest editor | imported>ScienceGen |
| Date of latest edit | 23:09, 5 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | PipISB is a drug used in scientific research which acts as a potent and selective inverse agonist of the cannabinoid receptor CB1. It is highly selective for the CB1 receptor over CB2, with a Kd at CB1 of 1.5nM vs over 7000nM at CB2, has good blood–brain barrier penetration, and can be conveniently radiolabelled... |
